Max Robotics — Global Service Robot Directory + US Certification

About

Rainer Cramer is a leading figure in the field of bioanalytical mass spectrometry, with a primary focus on advancing proteomics and biomarker discovery. His research centers on the development and application of innovative MALDI (Matrix-Assisted Laser Desorption/Ionization) mass spectrometry techniques to address critical challenges in biology and medicine. A major contribution is his pioneering work in prostate cancer biomarker discovery, where his 2013 study has garnered 48 citations, highlighting its significance in identifying clinically relevant molecular signatures. Cramer has also made substantial technical contributions to proteomics, notably through the development of a novel integrated robotics platform for two-dimensional difference gel electrophoresis, as detailed in his 2005 work on stress-induced changes in the *Schizosaccharomyces pombe* proteome (26 citations). Furthermore, his exploration of liquid support matrices for MALDI MS analysis (2016, 9 citations) represents a key methodological advancement, enabling more robust and reproducible analysis of complex peptide and proteome samples. Through these achievements, Cramer has established himself as a key innovator, bridging the gap between cutting-edge mass spectrometry technology and its practical application in disease research and systems biology.